GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+5.35%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$110M
AUM Growth
+$110M
(+14%)
Cap. Flow
+$13.9M
Cap. Flow
% of AUM
12.66%
Top 10 Holdings %
Top 10 Hldgs %
46.11%
Holding
87
New
22
Increased
11
Reduced
11
Closed
30
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$6.69M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
$6.17M |
| 3 |
Cooper Companies
COO
|
$5.42M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$5.24M |
| 5 |
Boston Scientific
BSX
|
$5.11M |
Top Sells
| 1 |
Prothena Corp
PRTA
|
$4.21M |
| 2 |
Bristol-Myers Squibb
BMY
|
$4.16M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$3.38M |
| 4 |
CHTP
CHELSEA THERAPEUTICS INT'L LTD
CHTP
|
$3.31M |
| 5 |
Arrowhead Research
ARWR
|
$3.04M |
Sector Composition
| 1 | Healthcare | 76.92% |
| 2 | Technology | 0.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Smith & Nephew
SNN
$16.2B
| $1.79M | 1.26% |
+50,000
| New | +$1.79M |
|
27
Edwards Lifesciences
EW
$47.7B
| $1.72M | 1.21% |
120,000
-60,000
| -33% | -$859K |
|
28
Assertio
ASRT
$78M
| $1.67M | 1.18% |
30,000
+5,000
| +20% | +$278K |
|
|
OREX
29
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $1.55M | 1.09% |
+25,000
| New | +$1.55M |
|
|
RCPT
30
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $1.49M | 1.05% |
+35,000
| New | +$1.49M |
|
|
NPSP
31
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $1.32M | 0.93% |
+40,000
| New | +$1.32M |
|
|
AVDL
32
Avadel Pharmaceuticals
AVDL
$1.45B
| $1.13M | 0.79% |
75,000
-225,000
| -75% | -$3.38M |
|
33
Catalyst Pharmaceutical
CPRX
$2.42B
| $1.11M | 0.78% |
437,296
+237,296
| +119% | +$600K |
|
34
TherapeuticsMD
TXMD
$12.8M
| $1.11M | 0.78% |
5,000
+1,000
| +25% | +$221K |
|
|
CYNO
35
DELISTED
Cynosure, Inc. Class A
CYNO
| $1.06M | 0.75% |
+50,000
| New | +$1.06M |
|
|
NSTG
36
DELISTED
NanoString Technologies, Inc.
NSTG
| $1.05M | 0.74% |
70,000
-5,000
| -7% | -$74.8K |
|
|
AIRM
37
DELISTED
Air Methods Corp
AIRM
| $1.03M | 0.73% |
+20,000
| New | +$1.03M |
|
|
INFI
38
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $956K | 0.67% |
+75,000
| New | +$956K |
|
|
UNIS
39
DELISTED
Unilife Corporation
UNIS
| $888K | 0.63% |
30,000
-50,000
| -63% | -$1.48M |
|
40
Heron Therapeutics
HRTX
$204M
| $862K | 0.61% |
+70,000
| New | +$862K |
|
|
OCRX
41
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $764K | 0.54% |
100,000
-135,000
| -57% | -$1.03M |
|
|
RVNC
42
DELISTED
Revance Therapeutics, Inc.
RVNC
| $680K | 0.48% |
20,000
| – | – |
|
|
BIOL
43
DELISTED
Biolase, Inc.
BIOL
| $660K | 0.47% |
24
| – | – |
|
|
DYAX
44
DELISTED
DYAX CORPORATION
DYAX
| $624K | 0.44% |
65,000
-135,000
| -68% | -$1.3M |
|
45
Assembly Biosciences
ASMB
$185M
| $262K | 0.18% |
+3,333
| New | +$262K |
|
46
Puma Biotechnology
PBYI
$258M
| $66K | 0.05% |
1,000
-10,330
| -91% | -$682K |
|
47
Align Technology
ALGN
$9.59B
| – | – |
-35,000
| Closed | -$1.81M |
|
|
AMRN
48
Amarin Corp
AMRN
$311M
| – | – |
-15,000
| Closed | -$543K |
|
|
49
Arrowhead Research
ARWR
$3.84B
| – | – |
-185,000
| Closed | -$3.04M |
|
50
Biogen
BIIB
$20.5B
| – | – |
-6,471
| Closed | -$1.98M |
|